Download Medical Notes on Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019 Medical Notes

About This Presentation

Description:The Evaluate Vantage Half-Year Review 2019 throws light on the most significant trends across pharma, medtech and biotech in the first half of 2019. The report talks about Mega-deals masking a significant decline in M&A activity for pharma and medtech, Bristol-Myers Squibb’s $74bn pending purchase of Celgene, Abbvie’s $63bn acquisition of Allergan, positioning 2019 to be a record year for pharma M&A spend, Verily’s $1bn round of funding in Q1, slowdown in the total number of M&A deals in both pharma and medtech, investors being cautious due to potential US drug reforms, etc.

Tags:Pharma, Biotech, Medtech, pharmaceutical, biopharma, Pharmaceutical Industry, report on pharmaceutical industry, US drug reforms

Published on: Jun 29, 2020 | Views : 992 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.4

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.4

What is Managed Care Pharmacy?

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

Indian Healthcare Industry Analysis by IBEF

The Pharmaceutical and Biotechnology Industries

Pharma 2020 Taxing times ahead

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

Diabetes Costs and Affordability in the United States

An overview of the ASEAN Pharma Market Report

Understanding Neuromuscular Disease Care Current State and Future Prospects

HEALTH A TO Z